2.59 The Best Doctor, Selinexor, & Annotation Services for NGS with Drs. Katsoulakis and Kelley

Plenary Session

Vinay Prasad, MD MPH

Health, Medicine, Policy, Oncology, Science & Medicine

4.7 • 789 Ratings

🗓️ 3 July 2020

⏱️ 75 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

This week we respond to some listener feedback from Dr. Christopher Booth and use it to talk about how to be the best hematologist-oncologist. We also discuss the SADAL study on Selinexor for patients with relapsed refractory diffuse large B-cell lymphoma, as published in The Lancet Haematology. Finally, we interview Drs. Eva Katsoulakis and Michael Kelley on their recent paper out in the Journal of Clinical Oncology: Precision Oncology, titled "Comparison of Annotation Services for Next-Generation Sequencing in a Large-Scale Precision Oncology Program". Selinexor: doi.org/10.1016/S2352-3026(20)30120-4 Annotation Services: doi.org/10.1200/PO.19.00118 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: https://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew

Transcript

Click on a timestamp to play from that location

0:00.0	Welcome to Plenary Session.
0:07.0	I'm your host, Dr. Vinay Prasad.
0:10.0	I'm a practicing hematologist, oncologist, and I'm associate professor of medicine.
0:14.0	I'm interested in issues at the intersection of medicine, oncology, and health policy, and that's what you're going to get on this podcast.
0:22.2	Welcome to Season 2.
0:25.1	This week on Plenary Session, I'm back in the studio, and we have a great show in store for you.
0:30.2	I've got Dr. Ava Katsulakis and Dr. Michael Kelly, and they're going to be talking with us
0:34.5	about a new paper in the JCO entitled Comparison of Annotation Services for Next Generation Sequencing in a Large Scale Precision
0:42.2	Oncology Program. Boy, that sounds like a mouthful, but what this is really about is what
0:47.0	happens when you compare recommendations for genetic testing for cancer tumors in two
0:52.8	different annotation services.
0:54.7	You're not going to want to miss this discussion. It is riveting.
0:57.3	But first, I've got a few things to talk about. As promised, I've got to nag you.
1:04.1	Because this is the last week of our pledge drive.
1:06.1	But I'm also going to talk about what does it really mean to be the best hematologist oncologist and selenexor.
1:12.3	That's what you've been waiting for. So you're going to hear it here on plenary sessions.
1:15.6	Stay tuned.
1:20.1	First up, well, this is it. You've waited it out.
1:27.8	This is the last week of the semi-annual Pledge Drive.
1:31.0	And after this week, you won't have to listen to me pestering you about supporting this podcast, even though I know you're listening and I know you enjoy this podcast.
1:40.6	This week, I wanted to outline the ways in which you could support this podcast on our semi-annual pledge drive.
1:46.2	Number one.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Vinay Prasad, MD MPH, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Vinay Prasad, MD MPH and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.